Scientists in Germany are reporting development of a urine test that finally can identify athletes who misuse certain kinds of insulin in an illicit attempt to enhance performance.
Mario Thevis and colleagues say that amateur and elite athletes reportedly have used long-acting, as well as rapid-acting, forms of insulin to gain an edge — although insulin doping’s actual ability to enhance performance remains uncertain.
Their article, scheduled for the April 1 edition of ACS’ Analytical Chemistry, a semi-monthly journal, states that scientists had not attempted to develop such a test in the past because of the presumption that it was impossible to detect insulin’s degradation products, the compounds formed as the body breaks down insulin.
Using urine samples from volunteers, including athletes with diabetes, the scientists were able to identify degradation products from Lantus insulin, one commonly used form of insulin. The test could not identify surreptitious use of two other forms of long-duration insulin, but the study uncovered clues that toward that goal. “Determination of long-acting insulin analogues in urine is of utmost interest for doping control purposes,” the study notes. “The developed and validated procedure provides a fast and reliable way to elucidate the potential misuse of the long-acting insulin analogue LAN in regular doping control specimens.”
Source: ACS
Related stories:
New lab test predicts risk of kidney injury after surgery
A simple laboratory test may provide a new way for doctors to identify patients at risk of developing potentially severe acute kidney injury (AKI) after surgery—up to three days before the problem would otherwise be detected, reports a pilot study in the May 2008 issue of the
Clinical Journal of the American Society of Nephrology.
Molecular medicine comes to the rescue
On Monday, August 14, Lilly Jaffe, a six-year-old North Shore suburban girl who had been diagnosed with type 1 diabetes when she was one month old, checked into the Clinical Research Center at the University of Chicago Medical Center. On Friday, August 18, she checked out, starting to make her own insulin, well on her way to insulin independence and ready to get in a few days of beach time in Michigan before starting first grade.
Potential to prevent loss of insulin in type 2 diabetes
There are two completely different diseases known as diabetes. Type 1 is an autoimmune condition that often starts in childhood or adolescence. Type 2 is a metabolic disorder sometimes associated with lifestyle. In both cases, the insulin-secreting beta cells in the pancreas die, albeit at different rates.
Common mutations linked to common obesity in Europeans
Scientists have discovered two common genetic mutations in people of European ancestry, which affect the production of several hormones controlling our appetite. The mutations have a significant effect on the risk of common obesity, according to research published today in
Nature Genetics.
A single mechanism for hypertension, insulin resistance and immune suppression
Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals.
Growth hormone's link to starvation may be clue to increasing life span
Researchers at UT Southwestern Medical Center have determined that starvation blocks the effects of growth hormone via a mechanism that may have implications in treating diabetes and extending life span.
Neuroscientists show insulin receptor signaling regulates structure of brain circuits
Impact of the signaling upon synapses and dendrites is shown for the first time in living creatures
A team of neuroscientists at Cold Spring Harbor Laboratory (CSHL) has demonstrated for the first time in living animals that insulin receptors in the brain can initiate signaling that regulates both the structure and function of neural circuits.
Weight Loss Plays Key Role in Diabetes Improvement Following Bariatric Surgery
Stomach-reduction surgery is excellent treatment for severe diabetes, but doctors at Duke University Medical Center caution that it is not a magic bullet.